Assertio Holdings Inc (ASRT)
1.025
+0.02
(+1.49%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Revenue (TTM): 152.07M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 152.07M |
| September 30, 2023 | 169.43M |
| June 30, 2023 | 168.02M |
| March 31, 2023 | 162.16M |
| December 31, 2022 | 156.23M |
| September 30, 2022 | 139.21M |
| June 30, 2022 | 130.47M |
| March 31, 2022 | 120.71M |
| December 31, 2021 | 111.01M |
| September 30, 2021 | 107.86M |
| June 30, 2021 | 116.95M |
| March 31, 2021 | 112.20M |
| December 31, 2020 | 106.28M |
| September 30, 2020 | 135.32M |
| June 30, 2020 | 155.91M |
| March 31, 2020 | 192.49M |
| December 31, 2019 | 229.50M |
| September 30, 2019 | 212.88M |
| June 30, 2019 | 235.22M |
| March 31, 2019 | 241.30M |
| December 31, 2018 | 311.77M |
| September 30, 2018 | 363.58M |
| June 30, 2018 | 381.50M |
| March 31, 2018 | 418.68M |
| December 31, 2017 | 380.72M |
| Date | Value |
|---|---|
| September 30, 2017 | 410.23M |
| June 30, 2017 | 425.34M |
| March 31, 2017 | 441.56M |
| December 31, 2016 | 455.90M |
| September 30, 2016 | 443.16M |
| June 30, 2016 | 437.49M |
| March 31, 2016 | 415.31M |
| December 31, 2015 | 342.73M |
| September 30, 2015 | 426.16M |
| June 30, 2015 | 372.79M |
| March 31, 2015 | 346.02M |
| December 31, 2014 | 390.36M |
| September 30, 2014 | 236.37M |
| June 30, 2014 | 222.34M |
| March 31, 2014 | 184.58M |
| December 31, 2013 | 134.21M |
| September 30, 2013 | 120.19M |
| June 30, 2013 | 116.01M |
| March 31, 2013 | 100.16M |
| December 31, 2012 | 90.82M |
| September 30, 2012 | 76.36M |
| June 30, 2012 | 59.60M |
| March 31, 2012 | 66.71M |
| December 31, 2011 | 132.97M |
| September 30, 2011 | 141.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
106.28M
Minimum
Dec 2020
235.22M
Maximum
Jun 2019
153.36M
Average
152.07M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Ocular Therapeutix Inc | 58.44M |
| Cormedix Inc | -- |
| Verastem Inc | -- |
| Puma Biotechnology Inc | 235.64M |
| CytomX Therapeutics Inc | 101.21M |